Peter Margitfalvi, Gabriela Kaliská, Branislav Stančák
Many patients requiring device implantation are on chronic oral anticoagulation or antitrombotic therapy. The periprocedural
management of their anticoagulation presents a dilemma to physicians, particularly in the subset of patients
with moderate-to-high risk of thromboembolic events. This article reviews strategies of perioperative management
of these patients. The standard strategy is to perform device implantation without cessation of oral anticoagulation.
The bridging strategy should be limited to some specific, high thromboembolic risk situations discussed in the en_article.